0
     

Report Added
Report already added
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.

“By product & service, the kits & reagents segment accounted for the largest share of the exosome research market”

Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents. Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.

“Asia Pacific: The fastest-growing region in the exosome research market.”

The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.

“North America: The North America region accounted for the largest share of the exosome research market”

North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:
By Respondent– Supply Side- 40%, Demand Side- 60%
By Designation— Executives- 25%, CXOs & Directors--30%, Managers - 45%
By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.

Research Coverage:
The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.
Table of Contents

1INTRODUCTION28
1.1OBJECTIVES OF THE STUDY28
1.2MARKET DEFINITION28
1.2.1INCLUSIONS & EXCLUSIONS28
1.3MARKET SCOPE29
FIGURE 1EXOSOME RESEARCH MARKET29
1.3.1YEARS CONSIDERED FOR THE STUDY29
1.4CURRENCY30
1.5LIMITATIONS30
1.6STAKEHOLDERS30
1.7SUMMARY OF CHANGES31
2RESEARCH METHODOLOGY32
2.1RESEARCH DATA32
FIGURE 2RESEARCH DESIGN32
2.1.1SECONDARY DATA33
2.1.2PRIMARY DATA34
FIGURE 3EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES34
2.2MARKET SIZE ESTIMATION35
FIGURE 4MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF EXOSOME RESEARCH IN THE MARKET35
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 202035
FIGURE 6AVERAGE MARKET SIZE ESTIMATION, 202036
2.3GROWTH RATE ASSUMPTIONS/GROWTH FORECAST37
FIGURE 7EXOSOME RESEARCH MARKET: CAGR PROJECTIONS, 2021–202638
FIGURE 8EXOSOME RESEARCH MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS CHALLENGES, AND OPPORTUNITIES38
FIGURE 9MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH39
2.4MARKET BREAKDOWN AND DATA TRIANGULATION40
FIGURE 10DATA TRIANGULATION METHODOLOGY40
2.5INSIGHTS FROM PRIMARIES41
FIGURE 11MARKET VALIDATION FROM PRIMARY EXPERTS41
2.6RESEARCH ASSUMPTIONS41
2.6.1COVID-19 SPECIFIC ASSUMPTIONS42
2.7RISK ANALYSIS42
3EXECUTIVE SUMMARY43
FIGURE 12EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)43
FIGURE 13EXOSOME RESEARCH MARKET, BY INDICATION,
2021 VS. 2026 (USD MILLION)44
FIGURE 14EXOSOME RESEARCH MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)44
FIGURE 15EXOSOME RESEARCH MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)45
FIGURE 16GEOGRAPHICAL SNAPSHOT: EXOSOME RESEARCH MARKET46
4PREMIUM INSIGHTS47
4.1EXOSOME RESEARCH MARKET OVERVIEW47
FIGURE 17RISING INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH47
4.2NORTH AMERICA: EXOSOME RESEARCH MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)48
FIGURE 18KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF
NORTH AMERICAN EXOSOME RESEARCH MARKET IN 202048
4.3EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021 VS. 2026 (USD MILLION)48
FIGURE 19LUNG CANCER SEGMENT TO DOMINATE THE MARKET IN 202648
5MARKET OVERVIEW49
5.1INTRODUCTION49
5.2MARKET DYNAMICS49
FIGURE 20EXOSOME RESEARCH MARKET: DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES49
TABLE 1EXOSOME RESEARCH MARKET: IMPACT ANALYSIS50
5.2.1DRIVERS50
5.2.1.1Increasing investments in pharmaceutical R&D and life science research50
5.2.1.2Rising cancer prevalence51
TABLE 2GLOBAL CANCER INCIDENCE, 2020 VS. 202551
5.2.1.3Increasing interest in exosome-based procedures51
5.2.2RESTRAINTS52
5.2.2.1Lack of skilled professionals52
5.2.3OPPORTUNITIES53
5.2.3.1Untapped emerging markets53
5.2.3.2Growing interest in exosome-based therapeutics53
5.2.3.3High demand for personalized medicine54
5.2.4CHALLENGE54
5.2.4.1Lack of gold standard protocols for development & production of exosomes54
5.3IMPACT OF COVID-19 OUTBREAK ON EXOSOME RESEARCH MARKET55
TABLE 3EXOSOME CONTRIBUTION IN COVID-19 CLINICAL RESEARCH55
TABLE 4ONGOING CLINICAL TRIALS FOR EXOSOME-BASED COVID-19 THERAPY56
5.4ECOSYSTEM AND VALUE CHAIN ANALYSIS56
FIGURE 21EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS57
5.5REGULATORY ANALYSIS59
6EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE60
6.1INTRODUCTION61
TABLE 5EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)61
6.2KITS & REAGENTS61
TABLE 6EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION)62
TABLE 7NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)62
TABLE 8EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)62
TABLE 9ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)63
TABLE 10EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)63
6.2.1ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS63
6.2.1.1Rapid and easy-to-use kits and reagents have gained significant demand in the past few years in the market63
TABLE 11EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)64
TABLE 12NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)64
TABLE 13EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)64
TABLE 14ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)65
6.2.2ANTIBODIES65
6.2.2.1High demand for exosome-based markers for disease detection is expected to propel the segment growth65
TABLE 15EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION,
2019–2026 (USD MILLION)65
TABLE 16NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)66
TABLE 17EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)66
TABLE 18ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)66
6.2.3OTHER KITS & REAGENTS67
TABLE 19OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION)67
TABLE 20NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)67
TABLE 21EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)68
TABLE 22ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)68
6.3SERVICES68
6.3.1PLAYERS OFFER END-TO-END RESEARCH SERVICES FOR LABS68
TABLE 23EXOSOME RESEARCH SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION)69
TABLE 24NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)69
TABLE 25EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)69
TABLE 26ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)70
6.4INSTRUMENTS70
6.4.1DEMAND FOR SCALABLE DEVELOPMENT OF EXOSOMES VIA HIGH THROUGHPUT SYSTEMS AUGMENTS THE SEGMENT GROWTH70
TABLE 27EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)71
TABLE 28NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)71
TABLE 29EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)71
TABLE 30ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)72
7EXOSOME RESEARCH MARKET, BY INDICATION73
7.1INTRODUCTION74
TABLE 31EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)74
7.2CANCER74
TABLE 32EXOSOME RESEARCH MARKET FOR CANCER, BY REGION,
2019–2026 (USD MILLION)75
TABLE 33NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)75
TABLE 34EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,
2019–2026 (USD MILLION)75
TABLE 35ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)76
TABLE 36EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)76
7.2.1LUNG CANCER76
7.2.1.1Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth76
TABLE 37EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION,
2019–2026 (USD MILLION)77
TABLE 38NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)77
TABLE 39EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION)77
TABLE 40ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)78
7.2.2BREAST CANCER78
7.2.2.1High prevalence and increasing awareness to drive the market for this segment78
TABLE 41EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION,
2019–2026 (USD MILLION)78
TABLE 42NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)79
TABLE 43EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION)79
TABLE 44ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)79
7.2.3PROSTATE CANCER80
7.2.3.1Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth80
TABLE 45EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION,
2019–2026 (USD MILLION)80
TABLE 46NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)80
TABLE 47EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)81
TABLE 48ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)81
7.2.4COLORECTAL CANCER81
7.2.4.1Increasing research activities and projects based on exosomes to drive the market for this segment81
TABLE 49EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)82
TABLE 50NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION)82
TABLE 51EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)82
TABLE 52ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION)83
7.2.5OTHER CANCERS83
TABLE 53EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION,
2019–2026 (USD MILLION)83
TABLE 54NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION)84
TABLE 55EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION)84
TABLE 56ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION)84
7.3NEURODEGENERATIVE DISEASES85
7.3.1POTENTIAL OF SALIVARY EXOSOMAL CONTENT AS BIOMARKERS HAS OPENED AVENUES IN RESEARCH FOR NEURODEGENERATIVE DISEASES85
TABLE 57EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES,
BY REGION, 2019–2026 (USD MILLION)85
TABLE 58NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)85
TABLE 59EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)86
TABLE 60ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)86
7.4CARDIOVASCULAR DISEASES86
7.4.1GROWING RESEARCH ON EXTRACELLULAR VESICLES FOR CVD TO PROPEL THE SEGMENT GROWTH86
TABLE 61EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2019–2026 (USD MILLION)87
TABLE 62NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)87
TABLE 63EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)87
TABLE 64ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)88
7.5INFECTIOUS DISEASES88
7.5.1POTENTIAL USE OF EXOSOMES IN DEVELOPING NOVEL COVID-19 TREATMENT SOLUTIONS IS EXPECTED TO DRIVE THE MARKET88
TABLE 65EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019–2026 (USD MILLION)89
TABLE 66NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)89
TABLE 67EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)89
TABLE 68ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION)90
7.6OTHER INDICATIONS90
TABLE 69EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION,
2019–2026 (USD MILLION)90
TABLE 70NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)91
TABLE 71EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)91
TABLE 72ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)91
8EXOSOME RESEARCH MARKET, BY APPLICATION92
8.1INTRODUCTION93
TABLE 73EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)93
8.2BIOMARKERS93
8.2.1BIOMARKERS FORM THE LARGEST APPLICATION SEGMENT93
TABLE 74EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION,
2019–2026 (USD MILLION)94
TABLE 75NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION)94
TABLE 76EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION)94
TABLE 77ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS,
BY COUNTRY, 2019–2026 (USD MILLION)95
8.3VACCINE DEVELOPMENT95
8.3.1POTENTIAL OF EXOSOMES TO COMBAT BACTERIAL INFECTIONS DRIVING INTEREST IN VACCINE APPLICATIONS95
TABLE 78EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)95
TABLE 79NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)96
TABLE 80EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)96
TABLE 81ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)96
8.4TISSUE REGENERATION97
8.4.1STUDIES CONDUCTED ON MOLECULAR PAYLOADS OF EXOSOMES TO ENHANCE TISSUE REGENERATION DRIVES MARKET GROWTH97
TABLE 82EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2019–2026 (USD MILLION)97
TABLE 83NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)97
TABLE 84EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION,
BY COUNTRY, 2019–2026 (USD MILLION)98
TABLE 85ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)98
8.5OTHER APPLICATIONS98
TABLE 86EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)99
TABLE 87NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 88EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)99
TABLE 89ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)100
9EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE101
9.1INTRODUCTION102
TABLE 90EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE,
2019–2026 (USD MILLION)102
9.2STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES102
9.2.1INCREASED DEMAND FOR MSC-EXOSOMES IN THERAPEUTICS AUGMENTS THE SEGMENT GROWTH102
9.3DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING SERVICES103
9.3.1SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO DRIVE MARKET GROWTH103
9.4OTHER MANUFACTURING SERVICES103
10EXOSOME RESEARCH MARKET, BY END USER104
10.1INTRODUCTION105
TABLE 91EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)105
10.2ACADEMIC & RESEARCH INSTITUTES105
10.2.1ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN
THE EXOSOME RESEARCH MARKET105
TABLE 92EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION)106
TABLE 93NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)106
TABLE 94EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)107
TABLE 95ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)107
10.3PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES107
10.3.1SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT107
TABLE 96EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)108
TABLE 97NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)108
TABLE 98EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)108
TABLE 99ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)109
10.4HOSPITAL & CLINICAL TESTING LABORATORIES109
10.4.1INCREASE IN ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT109
TABLE 100EXOSOME RESEARCH MARKET FOR HOSPITAL & CLINICAL TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION)109
TABLE 101NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)110
TABLE 102EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)110
TABLE 103ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)110
11EXOSOME RESEARCH MARKET, BY REGION111
11.1INTRODUCTION112
TABLE 104EXOSOME RESEARCH MARKET, BY REGION, 2019–2026 (USD MILLION)112
11.2NORTH AMERICA113
FIGURE 22NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT113
TABLE 105NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)114
TABLE 106NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)114
TABLE 107NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)114
TABLE 108NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)115
TABLE 109NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 110NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)115
TABLE 111NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)116
11.2.1US116
11.2.1.1High burden of cancer and favorable public and private funding for research activities to drive market growth116
FIGURE 23US CONTINUES TO DOMINATE THE DISTRIBUTION OF R&D COMPANIES
BY REGION/COUNTRY (2021)116
TABLE 112US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)117
TABLE 113US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)117
TABLE 114US: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)117
TABLE 115US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)118
TABLE 116US: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)118
TABLE 117US: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)118
11.2.2CANADA119
11.2.2.1Increasing funding for genome-based medical treatments to support market growth119
TABLE 118CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)119
TABLE 119CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)120
TABLE 120CANADA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)120
TABLE 121CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)120
TABLE 122CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)121
TABLE 123CANADA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)121
11.3EUROPE122
FIGURE 24EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT122
TABLE 124EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)123
TABLE 125EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)123
TABLE 126EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)123
TABLE 127EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)124
TABLE 128EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)124
TABLE 129EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)124
TABLE 130EUROPE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)125
11.3.1GERMANY125
11.3.1.1Strong academic research base bolsters market growth125
TABLE 131GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)125
TABLE 132GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 133GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)126
TABLE 134GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)126
TABLE 135GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)127
TABLE 136GERMANY: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)127
11.3.2UK127
11.3.2.1Growth in the life sciences industry to drive the market for exosome research in the UK127
TABLE 137UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)128
TABLE 138UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 139UK: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)128
TABLE 140UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)129
TABLE 141UK: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)129
TABLE 142UK: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)129
11.3.3FRANCE130
11.3.3.1Strong collaborative network between biotechnology entities and research institutes drives market growth130
TABLE 143FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)130
TABLE 144FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)130
TABLE 145FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)131
TABLE 146FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 147FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)131
TABLE 148FRANCE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)132
11.3.4REST OF EUROPE132
TABLE 149ROE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)132
TABLE 150ROE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)133
TABLE 151ROE: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)133
TABLE 152ROE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)133
TABLE 153ROE: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)134
TABLE 154ROE: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)134
11.4ASIA PACIFIC135
TABLE 155ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY,
2019–2026 (USD MILLION)135
TABLE 156ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)135
TABLE 157ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)136
TABLE 158ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)136
TABLE 159ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)136
TABLE 160ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)137
TABLE 161ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)137
11.4.1CHINA137
11.4.1.1Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are major factors driving market growth137
TABLE 162CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)138
TABLE 163CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)138
TABLE 164CHINA: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)138
TABLE 165CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)139
TABLE 166CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)139
TABLE 167CHINA: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)139
11.4.2JAPAN140
11.4.2.1High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosome research market in the country140
TABLE 168JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)140
TABLE 169JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)140
TABLE 170JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)141
TABLE 171JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 172JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)141
TABLE 173JAPAN: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)142
11.4.3REST OF ASIA PACIFIC142
TABLE 174ROAPAC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)142
TABLE 175ROAPAC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)143
TABLE 176ROAPAC: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)143
TABLE 177ROAPAC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)143
TABLE 178ROAPAC: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)144
TABLE 179ROAPAC: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)144
11.5REST OF THE WORLD144
TABLE 180ROW: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)145
TABLE 181ROW: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)145
TABLE 182ROW: EXOSOME RESEARCH MARKET, BY INDICATION,
2019–2026 (USD MILLION)145
TABLE 183ROW: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,
2019–2026 (USD MILLION)146
TABLE 184ROW: EXOSOME RESEARCH MARKET, BY APPLICATION,
2019–2026 (USD MILLION)146
TABLE 185ROW: EXOSOME RESEARCH MARKET, BY END USER,
2019–2026 (USD MILLION)146
12COMPETITIVE LANDSCAPE147
12.1INTRODUCTION147
12.2RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS147
FIGURE 25EXOSOME RESEARCH MARKET: STRATEGIES ADOPTED147
12.3MARKET SHARE ANALYSIS148
FIGURE 26EXOSOME RESEARCH MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)148
12.4COMPANY EVALUATION QUADRANT150
12.4.1STARS150
12.4.2EMERGING LEADERS150
12.4.3PERVASIVE PLAYERS150
12.4.4PARTICIPANTS150
FIGURE 27EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2020 (TOP 10 PLAYERS)151
12.5COMPETITIVE BENCHMARKING152
12.5.1COMPANY SERVICE FOOTPRINT (10 COMPANIES)152
FIGURE 28SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET152
12.6COMPETITIVE SCENARIO AND TRENDS153
12.6.1DEALS (2016–2019)153
TABLE 186EXOSOME RESEARCH MARKET: DEALS153
12.6.2PRODUCT LAUNCHES (2016–2019)154
TABLE 187EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES154
12.6.3OTHER DEVELOPMENTS (2016–2019)154
TABLE 188EXOSOME RESEARCH MARKET: OTHER DEVELOPMENTS154
13COMPANY PROFILES155
13.1KEY COMPANIES155
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1THERMO FISHER SCIENTIFIC, INC.155
TABLE 189THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW155
FIGURE 29THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT156
TABLE 190THERMO FISHER SCIENTIFIC, INC.: PRODUCT OFFERINGS156
TABLE 191THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS157
13.1.2SYSTEM BIOSCIENCES, LLC.159
TABLE 192SYSTEM BIOSCIENCES LLC: BUSINESS OVERVIEW159
TABLE 193SYSTEM BIOSCIENCES: PRODUCT & SERVICE OFFERINGS159
TABLE 194SYSTEM BIOSCIENCES LLC: DEALS160
13.1.3BIO-TECHNE161
TABLE 195BIO-TECHNE: BUSINESS OVERVIEW161
FIGURE 30BIO-TECHNE: COMPANY SNAPSHOT162
TABLE 196BIO-TECHNE: PRODUCT OFFERINGS162
TABLE 197BIO-TECHNE: PRODUCT LAUNCHES163
TABLE 198BIO-TECHNE: DEALS163
13.1.4QIAGEN165
TABLE 199QIAGEN: BUSINESS OVERVIEW165
FIGURE 31QIAGEN: COMPANY SNAPSHOT166
TABLE 200QIAGEN: PRODUCT OFFERINGS166
TABLE 201QIAGEN: DEALS167
13.1.5LONZA169
TABLE 202LONZA: BUSINESS OVERVIEW169
FIGURE 32LONZA: COMPANY SNAPSHOT170
TABLE 203LONZA: SERVICE OFFERINGS170
TABLE 204LONZA: DEALS171
13.1.6NX PHARMAGEN172
TABLE 205NX PHARMAGEN: BUSINESS OVERVIEW172
TABLE 206NX PHARMAGEN: SERVICE OFFERINGS172
13.1.7AMSBIO (AMS BIOTECHNOLOGY)173
TABLE 207AMSBIO: BUSINESS OVERVIEW173
TABLE 208AMSBIO: PRODUCT OFFERINGS173
13.1.8NANOSOMIX, INC.174
TABLE 209NANOSOMIX, INC.: BUSINESS OVERVIEW174
TABLE 210NANOSOMIX: PRODUCT OFFERINGS174
13.1.9MILTENYI BIOTEC175
TABLE 211MILTENYI BIOTEC: BUSINESS OVERVIEW175
TABLE 212MILTENYI BIOTEC: PRODUCT OFFERINGS175
13.1.10NORGEN BIOTEK CORP.176
TABLE 213NORGEN BIOTEK CORP.: BUSINESS OVERVIEW176
TABLE 214NORGEN BIOTEK: PRODUCT OFFERINGS176
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2OTHER PLAYERS177
13.2.1AETHLON MEDICAL, INC.177
TABLE 215AETHLON MEDICAL, INC.: COMPANY OVERVIEW177
13.2.2ANJARIUM BIOSCIENCES AG177
TABLE 216ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW177
13.2.3CILOA178
TABLE 217CILOA: COMPANY OVERVIEW178
13.2.4CLARA BIOTECH, INC.178
TABLE 218CLARA BIOTECH, INC.: COMPANY OVERVIEW178
13.2.5CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.179
TABLE 219CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: COMPANY OVERVIEW179
13.2.6ILIAS BIOLOGICS, INC.179
TABLE 220ILIAS BIOLOGICS, INC.: COMPANY OVERVIEW179
13.2.7NANOVIEW BIOSCIENCES180
TABLE 221NANOVIEW BIOSCIENCES: COMPANY OVERVIEW180
13.2.8RION, LLC180
TABLE 222RION, LLC: COMPANY OVERVIEW180
13.2.9CELL GUIDANCE SYSTEMS LLC181
TABLE 223CELL GUIDANCE SYSTEMS: COMPANY OVERVIEW181
13.2.10INOVIQ (BARD1 LIFE SCIENCES LTD.)181
TABLE 224INOVIQ: COMPANY OVERVIEW181
13.2.11NOVUS BIOLOGICALS182
TABLE 225NOVUS BIOLOGICALS: COMPANY OVERVIEW182
13.2.12BIOVISION INC.182
TABLE 226BIOVISION INC.: COMPANY OVERVIEW182
13.2.13PALL CORPORATION183
TABLE 227PALL CORPORATION: COMPANY OVERVIEW183
13.2.14EXOPHARM183
TABLE 228EXOPHARM: COMPANY OVERVIEW183
13.2.15EVERZOM184
TABLE 229EVERZOM: COMPANY OVERVIEW184
14APPENDIX185
14.1DISCUSSION GUIDE185
14.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL188
14.3AVAILABLE CUSTOMIZATIONS190
14.4RELATED REPORT190
14.5AUTHOR DETAILS191

Report Title: Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW